Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis.
Curdin ConradChristine-Elke OrtmannMarc VandemeulebroeckeTorben KasparekKristian ReichPublished in: Dermatology and therapy (2021)
CLEAR: NCT02074982; CLARITY: NCT02826603.